Phio Pharmaceuticals Statistics
Total Valuation
PHIO has a market cap or net worth of $13.94 million. The enterprise value is -$7.03 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PHIO has 11.62 million shares outstanding. The number of shares has increased by 659.91% in one year.
| Current Share Class | 11.62M |
| Shares Outstanding | 11.62M |
| Shares Change (YoY) | +659.91% |
| Shares Change (QoQ) | +71.14% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 8.23% |
| Float | 11.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.70 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.03
| Current Ratio | 16.03 |
| Quick Ratio | 15.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.95% and return on invested capital (ROIC) is -46.34%.
| Return on Equity (ROE) | -69.95% |
| Return on Assets (ROA) | -42.33% |
| Return on Invested Capital (ROIC) | -46.34% |
| Return on Capital Employed (ROCE) | -45.76% |
| Weighted Average Cost of Capital (WACC) | 8.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.93% in the last 52 weeks. The beta is 0.81, so PHIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | -40.93% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 1.61 |
| Relative Strength Index (RSI) | 46.85 |
| Average Volume (20 Days) | 150,244 |
Short Selling Information
The latest short interest is 520,525, so 4.48% of the outstanding shares have been sold short.
| Short Interest | 520,525 |
| Short Previous Month | 571,887 |
| Short % of Shares Out | 4.48% |
| Short % of Float | 4.51% |
| Short Ratio (days to cover) | 1.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | -4.62M |
| Operating Income | -9.22M |
| Pretax Income | -8.70M |
| Net Income | -8.70M |
| EBITDA | -9.22M |
| EBIT | -9.22M |
| Earnings Per Share (EPS) | -$1.45 |
Full Income Statement Balance Sheet
The company has $21.03 million in cash and n/a in debt, giving a net cash position of $21.03 million or $1.81 per share.
| Cash & Cash Equivalents | 21.03M |
| Total Debt | n/a |
| Net Cash | 21.03M |
| Net Cash Per Share | $1.81 |
| Equity (Book Value) | 20.15M |
| Book Value Per Share | 1.73 |
| Working Capital | 20.14M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$7.98 million and capital expenditures -$12,000, giving a free cash flow of -$7.99 million.
| Operating Cash Flow | -7.98M |
| Capital Expenditures | -12,000 |
| Depreciation & Amortization | 3,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.99M |
| FCF Per Share | -$0.69 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PHIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -659.91% |
| Shareholder Yield | -659.91% |
| Earnings Yield | -62.13% |
| FCF Yield | -57.08% |
Analyst Forecast
The average price target for PHIO is $14.00, which is 1,066.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 1,066.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 5, 2024. It was a reverse split with a ratio of 1:9.
| Last Split Date | Jul 5, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |